IMS Health

Malin to acquire Serenus Biotherapeutics

Wednesday, March 4, 2015 01:22 PM

Serenus Biotherapeutics, a San Francisco, Calif.-based specialty biopharmaceutical company, has secured investment of up to $43 million from Malin, an Ireland-based global life sciences company focused on healthcare.

More... »

Quest Diagnostics

Lycera names Paul Sekhri president and CEO

Thursday, February 5, 2015 12:58 PM

Lycera, a biopharmaceutical company developing breakthrough medicines to treat cancer and autoimmune disease, has named Paul Sekhri president, CEO and a member of the board of directors, effective immediately. Sekhri brings more than 25 years of operational experience in the life sciences industry, including business development and strategy, general management, drug development, and commercial strategy.  He succeeds Kathleen M. Metters, Ph.D., who currently serves as senior advisor to the company.

More... »


Impax to acquire Tower Holdings and Lineage Therapeutics

Wednesday, October 15, 2014 06:00 PM

Hayward, Calif.-based Impax Laboratories will acquire Tower Holdings, including operating subsidiaries CorePharma, based in Middlesex, N.J., Amedra Pharmaceuticals, based in Horsham, Penn., and Lineage Therapeutics, also based in Horsham, for $700 million in cash, subject to certain customary purchase price adjustments.

More... »

IMS Health acquires Cegedim’s CRM and software developer unit

Thursday, June 26, 2014 12:45 PM

IMS Health, which in the last year has been actively making acquisitions leading up to its April IPO, has announced its intention to acquire Paris-based Cegedim’s information solutions and customer relationship management (CRM) business for approximately $520 million in cash.

More... »

IMS Health acquires Forcea

Thursday, May 8, 2014 01:14 PM

IMS Health, a global information and technology services company, has acquired Forcea, a Belgium-based provider of business intelligence applications and analytics for hospitals and life sciences organizations.

More... »

IMS Health files for IPO

Monday, January 6, 2014 03:02 PM

IMS Health, a global information and technology services company, has publicly filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock.

More... »

Covance launches managed markets services

Friday, August 9, 2013 01:04 PM

Princeton, N.J.-based CRO Covance has created a new service offering focused on providing its biopharmaceutical and medical device clients support to effectively manage contracts in managed markets.

More... »

Greenphire, IMS Health integrate eClinicalGPS and GrantPlan

Wednesday, June 19, 2013 11:49 AM

Greenphire has launched a strategic integration of its eClinicalGPS, a global investigator payment technology, with IMS Health’s GrantPlan, a benchmarking and contracting tool for global clinical site grants.

More... »

IMS Health acquires Incential Software

Monday, June 10, 2013 11:32 AM

IMS Health has acquired Incential Software, a Software-as-a-Service (SaaS) company based in Raleigh, N.C., to advance its sales performance management capabilities for life sciences organizations worldwide. Incential delivers cloud-based technology and services that integrate incentive compensation, data management and business intelligence applications for effective, results-driven sales operations.

More... »

IMS Health advances cloud-based social media analytics with acquisition of Semantelli

Wednesday, May 1, 2013 02:09 PM

IMS Health, a provider of information, services and technology for the healthcare industry, has acquired Semantelli, a Bridgewater, N.J.-based social media analytics company, to extend its marketing and consumer engagement capabilities for healthcare organizations around the world.

More... »


CWWeekly

March 30

Icon, Carnegie Mellon partner to research ways to improve study patients' understanding of Informed Consent

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs